首页> 外国专利> (R) - N - (3 - (1H - indazol - 7 - methyl - 5 - il) 1 - (4 - (1 - metilpiperidin - 4-yl) piperazin-1-yl) - 1 - oxopropan - 2 - il) - 4 - (2 - oxo - 1.2 - dihidroquinolin - 3 Piperidine - il) - 1 Receptor Antagonist CGRP - carboxamide.

(R) - N - (3 - (1H - indazol - 7 - methyl - 5 - il) 1 - (4 - (1 - metilpiperidin - 4-yl) piperazin-1-yl) - 1 - oxopropan - 2 - il) - 4 - (2 - oxo - 1.2 - dihidroquinolin - 3 Piperidine - il) - 1 Receptor Antagonist CGRP - carboxamide.

机译:(R)-N-(3-(1H-吲唑-7-甲基-5-il)1-(4-(1-甲哌啶-4-基)哌嗪-1-基)-1-氧丙烷-2-il )-4-(2-氧代-1.2-二氢喹啉-3哌啶-il)-1受体拮抗剂CGRP-甲酰胺。

摘要

Compound of Formula 1, (R) - N - (3 - (1H - indazol - 7 - methyl - 5 - (ii) - 1 - (4 - (1 - metilpiperidin piperazin - 4-yl) - 1 - (ii) - 1 - oxopropan - 2 - (ii) - 4 - (2 - oxo - 1.2 - dihidroquinolin II) piperidin - 3 - 1 - carboxamide, including pharmaceutically acceptable salts, which is a receptor antagonist of CGRP.Also compositions and pharmaceutical use of the compound in the treatment of disorders associated with CGRP, including migrana, Neurogenic Neurogenic vasodilation, inflammation, damage of heat shock associated with Menopause, hot flashes, respiratory diseases inflamato Rias, such as Asthma, chronic obstructive pulmonary disease (COPD) and cancer.
机译:式1的化合物,(R)-N-(3-(1H-吲唑-7-甲基-5-(ii)-1-(4-(1-甲哌啶哌嗪-4-yl)-1-(ii)) -1-氧丙烷-2-(ii)-4-(2-氧代-1.2-二氢喹啉II)哌啶-3-1-羧酰胺,包括药学上可接受的盐,它是CGRP的受体拮抗剂。该化合物可用于治疗与CGRP相关的疾病,包括偏头痛,神经源性神经源性血管舒张,炎症,与更年期相关的热休克,潮热,呼吸系统炎,例如哮喘,慢性阻塞性肺病(COPD)和癌症。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号